In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir.

The US journal "Science" has named the development of the drug Lenacapavir as this year's "Breakthrough of the Year". The ...

Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...

LOS ANGELES, Dec. 13 (Xinhua) -- An injectable HIV drug with novel mechanism was named on Thursday by the influential U.S. journal "Science" as Breakthrough of the Year. The drug, named lenacapavir, ...

A court ruling doesn’t permit schools to “force-vaccinate” students, it addresses civil liability for accidentally ...

But doing so still requires “substantial breakthroughs in synthetic cell research”, the scientists said. HIV gamechanger: Lenacapavir study participant explains Although the capability to engineer ...

Satellite images reveal Russian military equipment being prepared for loading, a possible prelude to its withdrawal from Syria. Travis Timmerman, an American who was found earlier this week, was ...

Trump Treasury Pick’s Plan: Boost Growth, Cut Deficit, More Oil and Gas Scott Bessent has outlined a strategy to jump-start a U.S. economy that has been saddled with inflation and sluggish ...

Lyon have made a last-ditch attempt to lure England and Lions hooker Luke Cowan-Dickie away from Sale Sharks just over a week afte… The 31-year-old is one of eight members of this year’s Rugby ...